Available
$125.00
Strict Regulatory Notice: This agent is synthesized strictly for laboratory-based research and analytical purposes. It is not intended for human or veterinary use, nor for medical, household, or cosmetic applications. Please review our Terms of Service thoroughly before finalizing your acquisition.
**GLP Compounds Payment Notice**
GLP compounds are not eligible for credit card purchases. When a GLP product is present in your shopping cart, all credit card payment options will be automatically removed. Please select an alternative payment method, such as ACH, Cryptocurrency, or Zelle.
Available
| Parameter | Specification / Details |
|---|---|
| Primary Compound Name | Cagrilintide (Long-Acting Amylin Analog) |
| CAS Registry Number | 1415456-99-3 |
| IUPAC Designation | (Polypeptide sequence of 39 amino acids featuring a C20 fatty diacid side chain) |
| Synonyms / Trade Names | CAG, NN1215, AM833 |
| PubChem CID | 162035619 |
| Molecular Formula | C194H302N50O62 |
| Molar Mass / Weight | 4314.8 g/mol |
| Physical Appearance | White lyophilized (freeze-dried) solid/powder |
| Solubility Profile | Highly soluble in Bacteriostatic Water and sterile water |
| Tested Purity | ≥98% via HPLC |
| Active Ingredient (Total) | 5mg per vial |
| Dry / Powder Formulations | Lyophilized powder |
| Alternative Formulations | Pramlintide (Short-acting Amylin), CagriSema (Semaglutide/Cagrilintide blend) |
| Storage Guidelines | Lyophilized: Store at -20°C for long-term stability. Protect from light. Reconstituted: Must be refrigerated at 2°C to 8°C. |
| Estimated Shelf Life | 24 months from manufacture date (lyophilized) |
| Safety Documentation | Standard SDS available for Cagrilintide |
| Terms of Application | For laboratory research purposes only. Not for human or veterinary use. Investigated for the modulation of amylin and calcitonin receptors, evaluating synergistic effects on satiety, gastric emptying, and energy homeostasis when assayed alongside GLP-1 receptor agonists in in-vitro models. |
GLP-4 CAG (5mg) is a specialized research compound developed for the rigorous study of amylin receptor agonism and its synergistic effects when co-administered with GLP-1 analogs. Synthesized as a long-acting amylin mimetic, it serves researchers examining delayed gastric emptying, glucagon suppression, and central satiation pathways in neurological assays.
At 4 Amino Labs, we provide this compound in a highly purified format to ensure experimental reproducibility.
Scientific Literature Reference: The biochemical pathway of long-acting amylin analogs acting synergistically with GLP-1 receptor agonists to modulate feeding behavior and gastric motility is heavily documented. See: Kruse, T., et al. (2021). “Cagrilintide, a long-acting amylin analogue.” Journal of Pharmacology and Experimental Therapeutics.
Our GLP-4 CAG undergoes a multifaceted verification process via independent High-Performance Liquid Chromatography (HPLC) to ensure a purity threshold of ≥ 98%.
Researchers utilizing GLP-4 CAG typically focus on the following biochemical mechanisms:
To maintain the molecular integrity of GLP-4 CAG, the following storage parameters are recommended:
This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4 Amino Lab does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.
$55.00
$29.99
$95.00
$64.00
